The global Pharmaceutical Grade Niacin market continues its upward trajectory, with its valuation reaching USD 593.80 million in 2023. Industry projections indicate a steady growth path at a CAGR of 5.10%, culminating in an estimated market size of USD 929.10 million by 2032. North America, currently valued at USD 168.55 million (2023), shows particular promise with a growth rate of 4.37% CAGR...